Motor Neurone Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are an adult (any gender) who is willing to give written consent to take part in the study
- You are covered by a social security (health insurance) scheme
- If you have ALS: You have been diagnosed with ALS using established medical criteria, and either have a family history of ALS, carry a known gene mutation linked to ALS, developed symptoms before age 30, or have a non-inherited form of ALS
- If you carry an ALS-related gene mutation: You carry a gene mutation known to cause ALS but have not yet developed any symptoms
- If you are a healthy volunteer: You are a healthy person who can be matched by age and gender to serve as a comparison participant
Who may not be able to join:
- You have a known skin condition (such as acne, eczema, psoriasis, melanoma, skin cancer, rosacea, or scabies) that the doctor feels would make a skin biopsy (small skin sample) unsafe for you
- A recent blood test (within the last 3 months) shows your platelet count (cells that help blood clot) is below 75,000/mm³
- You have a known allergy to lidocaine or prilocaine (local anaesthetic medicines used to numb the skin)
- You are currently pregnant or breastfeeding
- You are under legal guardianship or a similar form of legal protection
- Your overall health condition makes it unsuitable for you to have a skin sample taken, in the opinion of the doctor running the trial
- You are already taking part in another clinical drug trial or study that would interfere with this one
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 33142162472
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection of cytoplasmic TDP-43, TIA1 and/or p62 aggregates in patient fibroblasts
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.